Key Points
- Sarah MacAulay purchased 50,000 shares of Ct Healthcare Trust (LON:CTHT) on April 23 at an average price of GBX 139 per share, a total transaction of £69,500.
- The stock opened at GBX 138.60, has a market capitalization of £78.06 million, a negative P/E of -5.01, and a one‑year range of GBX 122.43–142.80.
- Ct Healthcare Trust is a UK‑listed investment trust focused on the healthcare and life sciences sectors, investing across pharmaceuticals, biotech, medical devices, diagnostics and services to pursue long‑term capital growth.
Ct Healthcare Trust (red) (LON:CTHT - Get Free Report) insider Sarah MacAulay bought 50,000 shares of the company's stock in a transaction dated Thursday, April 23rd. The shares were acquired at an average cost of GBX 139 per share, for a total transaction of £69,500.
Ct Healthcare Trust (red) Price Performance
LON:CTHT opened at GBX 138.60 on Friday. The stock has a market capitalization of £78.06 million and a P/E ratio of -5.01. Ct Healthcare Trust has a one year low of GBX 122.43 and a one year high of GBX 142.80.
About Ct Healthcare Trust (red)
(
Get Free Report)
CT Healthcare Trust plc (LON: CTHT) is a United Kingdom–listed investment trust that concentrates on the healthcare and life sciences sectors. The company's principal activity is investing in quoted healthcare equities and related instruments with the objective of delivering long‑term capital growth for its shareholders through exposure to companies involved in pharmaceuticals, biotechnology, medical devices, diagnostics and healthcare services.
The trust builds a diversified portfolio across a range of healthcare sub‑sectors and geographies, typically taking positions in established and emerging companies that the board and investment manager consider to have attractive growth prospects, innovative technologies or strong market positions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
